Community Support Program for Lung Cancer Screening

Not Applicable

Completed

• Conditions: Lung Cancer; Behavior

• Registration Number: NCT06207435
• Lead Sponsor: Abramson Cancer Center at Penn Medicine

Brief Summary

The research study aims to create a program for lung cancer screening attendance

Detailed Description

The overall objective of this project is to demonstrate the impact of a community support program (CSP) on improving adherence to LCS follow-up guidelines in an urban environment. The project aims to collaborate with community partners to develop an infrastructure and iterative process to provide social support to community members that facilitates obtaining their follow-up LDCT for LCS. It utilizes novel population level data that includes geospatial analysis of neighborhood-level data of patients residing in Philadelphia who have received a LDCT for LCS. This allows for targeted community level interventions and the ability to evaluate impact on a population level.

A Community Support Program Representative will reach out to eligible patients via telephone. The CSP Representative and Patient Navigator will communicate with consented patient directly, assist with travel and the appointment. The PN will log the date of the appointment, zip code of the patient and the adherence (or lack of) of the appointment completion. We will utilize Lyft transportation vouchers to provide rides to participants from their home location in West Philadelphia to and from the Penn Medicine downtown hospital locations on the day of their LDCT.

Study Timeline

• Study Start: 2023-02-10
• Study First Submitted: 2023-12-20
• Study First Submitted QC: 2024-01-04
• Study First Posted: 2024-01-17
• Primary Completion: 2024-08-12
• Study Completion: 2024-08-30
• Results First Submitted: 2025-06-03
• Status Verified: 2025-08
• Results First Submitted QC: 2025-08-28
• Last Update Submitted: 2025-08-28
• Results First Posted: 2025-09-02
• Last Update Posted: 2025-09-02

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 242

Inclusion Criteria

• Upcoming or missed follow-up LDCT (low dose CT)
• West Philadelphia resident
• Between 18-89 years' old

Exclusion Criteria

• No upcoming LDCT
• Lives outside West Philadelphia
• Outside age range

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Percentage of Scheduled Lung Cancer Screening Appointments Attended by Participants	12 months	The Primary Outcome measures the rate of appointment attendance across three groups: West Philadelphia CSP Participants (eligible West Philadelphia residents who opted into the CSP), West Philadelphia Non CSP Participants (eligible West Philadelphia residents who did not opt into the CSP), and Southwest Philadelphia Residents (patients who did not receive an option to participate in the CSP).

Secondary Outcome Measures

Name	Time	Method
Percentage of CSP Enrollment	12 months	The Secondary outcome is a measurement of the percentage of eligible participants (West Philadelphia residents) who chose to opt into the CSP (as opposed to eligible participants who did not).

Trial Locations

Locations (1)

University of Pennsylvania; 🇺🇸 Philadelphia, Pennsylvania, United States